BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The radiopharmaceutical race is on and pharma leaders such as 
 AstraZenca\, BMS \, Eli Lilly\, Novartis and Sanofi are not getting left 
 behind. Bolstering discovery pipelines through acquisitions of preclinica
 l Mariana Oncology\, Radionetics and Aktis Oncology\, the field is turnin
 g to cutting-edge\, novel targeting molecules and new targets to address 
 more unmet medical need. With strong clinical efficacy from blockbuster d
 rugs Pluvicto and Lutathera\, radiopharmaceutical leaders are looking for
  the next application of this highly efficacious and potent modality!\n\n
 The inaugural Targeted Radiopharmaceuticals Target Selection and Drug Des
 ign Summit is your dedicated forum to advancing novel radiopharmaceutical
  drug discovery. Delve deep into target mining\, screening\, discovery an
 d selection from ROR1\, uPAR\, B7-H3\, NECTIN-4\, CAIX and more. Understa
 nd advances in radiobiological\, radiodecay and radiation absorption mech
 anisms to inform optimal targeting strategies from small molecule\, pepti
 de\, nanobodies\, antibody fragments as well as linker and chelator techn
 ologies for enhanced PK. Bringing it all together\, gain a commercial per
 spective to enhance your strategic decision-making in target selection an
 d novel drug rationale within this highly dynamic field.\n\nIncorporating
  key insights from radiopharmaceuticals’ leading drug discovery minds fro
 m medicinal chemistry\, radiobiology\, biology\, discovery\, R AND D\, ph
 armacology\, computational biology\, commercial strategy and many more\, 
 this is the only global opportunity to gain practical insights into your 
 approaches\, from target selection to drug design.\n\nUniting the discove
 ry experts pioneering the field\, join the inaugural TRP Target Selection
  and Drug Design Summit to understand exactly what targets match the stro
 ng therapeutic index of TRPs and uncover optimal targeting strategies for
  stellar drug discovery!\n\n&nbsp\;\n\nTime: 9:00 AM - 4:30 PM\n
DTEND:20250227T163000
DTSTAMP:20260512T232946Z
DTSTART:20250225T090000
LOCATION:Revere Hotel Boston Common\, 200\, Stuart Street\, Boston\, Massa
 chusetts\, 02116\,
SEQUENCE:0
SUMMARY:The radiopharmaceutical race is on and pharma leaders such as Astr
 aZenca\, BMS \, Eli Lilly\, Novartis and Sanofi are not getting left behi
 nd. Bolster...
UID:ab0a65c4-0046-40d7-8792-6d21873c98f8
END:VEVENT
END:VCALENDAR
